Wells Fargo’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $716M | Sell |
|
|||||
|
2025
Q2 | $715M | Sell |
|
|||||
|
2025
Q1 | $732M | Sell |
|
|||||
|
2024
Q4 | $629M | Sell |
|
|||||
|
2024
Q3 | $603M | Sell |
|
|||||
|
2024
Q2 | $501M | Buy |
|
|||||
|
2024
Q1 | $518M | Sell |
|
|||||
|
2023
Q4 | $577M | Buy |
|
|||||
|
2023
Q3 | $527M | Sell |
|
|||||
|
2023
Q2 | $557M | Sell |
|
|||||
|
2023
Q1 | $631M | Sell |
|
|||||
|
2022
Q4 | $703M | Sell |
|
|||||
|
2022
Q3 | $526M | Sell |
|
|||||
|
2022
Q2 | $528M | Sell |
|
|||||
|
2022
Q1 | $519M | Buy |
|
|||||
|
2021
Q4 | $533M | Sell |
|
|||||
|
2021
Q3 | $642M | Sell |
|
|||||
|
2021
Q2 | $643M | Buy |
|
|||||
|
2021
Q1 | $588M | Sell |
|
|||||
|
2020
Q4 | $546M | Buy |
|
|||||
|
2020
Q3 | $547M | Buy |
|
|||||
|
2020
Q2 | $537M | Sell |
|
|||||
|
2020
Q1 | $703M | Buy |
|
|||||
|
2019
Q4 | $585M | Sell |
|
|||||
|
2019
Q3 | $627M | Buy |
|
|||||
|
2019
Q2 | $643M | Buy |
|
|||||
|
2019
Q1 | $604M | Buy |
|
|||||
|
2018
Q4 | $568M | Buy |
|
|||||
|
2018
Q3 | $696M | Buy |
|
|||||
|
2018
Q2 | $591M | Sell |
|
|||||
|
2018
Q1 | $754M | Sell |
|
|||||
|
2017
Q4 | $800M | Sell |
|
|||||
|
2017
Q3 | $937M | Buy |
|
|||||
|
2017
Q2 | $802M | Sell |
|
|||||
|
2017
Q1 | $798M | Buy |
|
|||||
|
2016
Q4 | $810M | Sell |
|
|||||
|
2016
Q3 | $1.02B | Buy |
|
|||||
|
2016
Q2 | $970M | Sell |
|
|||||
|
2016
Q1 | $1.14B | Sell |
|
|||||
|
2015
Q4 | $1.3B | Sell |
|
|||||
|
2015
Q3 | $1.46B | Buy |
|
|||||
|
2015
Q2 | $1.59B | Sell |
|
|||||
|
2015
Q1 | $1.44B | Sell |
|
|||||
|
2014
Q4 | $1.4B | Buy |
|
|||||
|
2014
Q3 | $1.49B | Sell |
|
|||||
|
2014
Q2 | $1.2B | Sell |
|
|||||
|
2014
Q1 | $1.16B | Sell |
|
|||||
|
2013
Q4 | $1.28B | Buy |
|
|||||
|
2013
Q3 | $1.04B | Sell |
|
|||||
|
2013
Q2 | $861M | Buy |
|